Ausgabe 1/2021
Inhalt (12 Artikel)
New surveillance guidelines for Li-Fraumeni and hereditary TP53 related cancer syndrome: implications for germline TP53 testing in breast cancer
D. Gareth Evans, Emma R. Woodward
The CAPP II trial of aspirin in Lynch syndrome/HNPCC: is it time for everyone to be treated?
Patrick M. Lynch
Improving primary care identification of familial breast cancer risk using proactive invitation and decision support
Nadeem Qureshi, Brittany Dutton, Stephen Weng, Christina Sheehan, Wendy Chorley, John F. R. Robertson, Denise Kendrick, Joe Kai
Chemoprevention in familial adenomatous polyposis: past, present and future
Phillip M. Kemp Bohan, Gautam Mankaney, Timothy J. Vreeland, Robert C. Chick, Diane F. Hale, Jessica L. Cindass, Annelies T. Hickerson, Daniel C. Ensley, Vance Sohn, G. Travis Clifton, George E. Peoples, Carol A. Burke
Prospective observational data informs understanding and future management of Lynch syndrome: insights from the Prospective Lynch Syndrome Database (PLSD)
Toni T. Seppälä, Mev Dominguez-Valentin, Julian R. Sampson, Pål Møller
Low accuracy of self-reported family history of melanoma in high-risk patients
Nicholas D. Flint, Michael D. Bishop, Tristan C. Smart, Jennifer L. Strunck, Kenneth M. Boucher, Douglas Grossman, Aaron M. Secrest
Small fraction of testicular cancer cases may be causatively related to CHEK2 inactivating germ-line mutations: evidence for somatic loss of the remaining CHEK2 allele in the tumor tissue
Valeriya I. Ni, Alexandr O. Ivantsov, Mariya A. Kotkova, Sofia V. Baskina, Elena V. Ponomareva, Rashida V. Orlova, Eldar E. Topuzov, Kirill K. Kryukov, Kseniya V. Shelekhova, Svetlana N. Aleksakhina, Anna P. Sokolenko, Evgeny N. Imyanitov
Two cases of somatic STK11 mosaicism in Danish patients with Peutz–Jeghers syndrome
Anne Marie Jelsig, Birgitte Bertelsen, Isabel Forss, John Gásdal Karstensen
Germline variants discovered in lymphoma patients undergoing tumor profiling: a case series
Anthony J. Scott, Molly C. Tokaz, Michelle F. Jacobs, Arul M. Chinnaiyan, Tycel J. Phillips, Ryan A. Wilcox
Report of the fifth meeting of the European Consortium 'Care for CMMRD' (C4CMMRD), Leiden, The Netherlands, July 6th 2019
M. Suerink, K. Wimmer, L. Brugieres, C. Colas, R. Gallon, T. Ripperger, P. R. Benusiglio, E. M. A. Bleiker, Z. Ghorbanoghli, Y. Goldberg, J. C. H. Hardwick, M. Kloor, M. le Mentec, M. Muleris, M. Pineda, C. Ruiz-Ponte, H. F. A. Vasen
Complete response of hereditary leiomyomatosis and renal cell cancer (HLRCC)-associated renal cell carcinoma to nivolumab and ipilimumab combination immunotherapy by: a case report
Yasuhiro Iribe, Mitsuko Furuya, Yousuke Shibata, Masato Yasui, Makoto Funahashi, Junichi Ota, Hiromichi Iwashita, Yoji Nagashima, Hisashi Hasumi, Narihiko Hayashi, Kazuhide Makiyama, Keiichi Kondo, Reiko Tanaka, Masahiro Yao, Noboru Nakaigawa